Found 10 matching trials
A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma PHASE3 Multiple myeloma is a cancer of the plasma cells in the bone marrow.
The m...
Show More Location
Infirmary Health - Diagnostic & Medical Clinic (DMC)
Learn More & Join Trial
LIME Study (LFB IVIg MMN Efficacy Study) PHASE3 The aim of this study is to evaluate the efficacy and safety of I10E (LFB 1...
Show More Location
CHU de Bordeaux -Hôpital Haut-Lévêque
Learn More & Join Trial
Immune Globulin Subcutaenous (Human), 20% PHASE2 The purpose of the study is to develop a 20% subcutaneous immunoglobulin tr...
Show More Location
Medizinische Universität Wien / AHK Wien (General Hospital Vienna), Universitätsklinik für Kinder- und Jugendheilkunde
Learn More & Join Trial
Study of the Effectiveness of Intravenous Immune Globulin (10%) for the Treatment of Multifocal Motor Neuropathy PHASE3 The purpose of the study is to evaluate the efficacy (effect on grip streng...
Show More Location
Multiple Locations
Learn More & Join Trial
rATG Versus rATG Combined With Intravenous Immunoglobulin (IVIG) Induction Immunosuppression in HLA Incompatible Transplantation (INHIBIT) PHASE3 This study aims to prove similar efficacy of PE/rATG (intervention) and PE/...
Show More Location
Institute for Clinical and Experimental Medicine
Learn More & Join Trial
Tolerability and Safety of Immune Globulin Subcutaneous Solution (IGSC) and rHuPH20 in PID PHASE3 The original purpose of the study is to assess the long-term safety, tolera...
Show More Location
Multiple Locations
Learn More & Join Trial
A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild-to-Moderate Alzheimer´s Disease PHASE3 The purpose of this study was to evaluate the efficacy and safety of 2 dose...
Show More Location
Multiple Locations
Learn More & Join Trial
Gammagard Liquid and rHuPH20 in PID PHASE3 The purpose of the study is to develop a subcutaneous treatment option for ...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of HyQvia and Gammagard Liquid (Kiovig) in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) PHASE3 The aim of this study is to learn more about the following treatment option...
Show More Location
Barrow Neurological Institute
Learn More & Join Trial
Post-Authorization Safety, Tolerability and Immunogenicity Evaluation of HyQvia in Pediatric PIDD Subjects PHASE4 The purpose of the study is to acquire additional data on safety, tolerabil...
Show More Location
Fakultni nemocnice Brno Odd. Detska klinika
Learn More & Join Trial